Franco Pui Tak Lai
Papers
1
Total Citations
2
H-Index
1
About
Franco Pui Tak Lai is a pioneering urological surgeon and researcher whose work sits at the intersection of minimally invasive surgery and oncology, with a particular focus on prostate cancer. His major contributions center on the clinical application of Aquablation—a robotic waterjet resection technique—to treat men with prostate cancer suffering from lower urinary tract symptoms. In his most cited study, Lai prospectively evaluated the impact of this procedure on circulating tumor cells (CTCs) in men with localized disease and MRI-visible lesions. This work is notable for being among the first to assess the oncological safety of Aquablation by tracking CTC dynamics during surgery, addressing a critical gap in the field. While his citation count is still growing, the novelty and clinical relevance of his research have already established him as an emerging authority in urologic oncology. His findings offer promising evidence that Aquablation may provide effective symptom relief without compromising cancer control, a balance that is notoriously difficult to achieve. For students and researchers, Lai’s work exemplifies how modern surgical innovation can be rigorously tested against oncological principles, paving the way for safer, less invasive treatments.
Research Focus
Key Achievements
Top Papers
- 1